There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are ...

The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by ...

Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. The device is an atrio-ventricular interval modulation therapy, meaning it ...

In 2010, the Affordable Care Act redefined access to healthcare. Fifteen years later, we find ourselves facing a different kind of challenge — not who can enter the system, but how the system ...